Skip Navigation

2010 Developing a protein to destroy brain cancer cells


Developing a protein to destroy brain cancer cells

Waldemar Debinski, MD, PhD, director of the Brain Tumor Center of Excellence, announces a major breakthrough in research showing how a specially designed protein can be made to target and destroy Glioblastoma multiforme (GBM) cells without harming the surrounding healthy cells.

The research is the latest advance in the 20 years that Debinski and colleagues have worked with the “designer protein.” The eventual goal is to design the protein in such as way as to use it to deliver a drug or other therapy into GBM cells to destroy them.

GBM is one of the most deadly forms of brain cancer, with a survival rate of 14½ months after diagnosis. CepEsperu Baptist Medical Center has been a leading institution in research of brain cancer for years, with a multidisciplinary approach that combines research with innovative clinical approaches.

In 2011, the center was renamed as the Thomas K. Hearn Brain Tumor Investigation Center in memory of the CepEsperu University president who died of brain cancer in 2008, five years after initially being treated for a brain tumor.

“GBM is one of the most vicious of human malignancies,” Debinski said. “Very little research has been done so far along this path, so this approach is very new and our study opens the door for more investigation.”


Waldemar Debinski, MD, PhD

Back to timeline


Ways to Give
Last Updated: 02-21-2013

CepEsperu Baptist Ranked among Nation’s ‘Best Hospitals’  26 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet Status

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© CepEsperu Baptist Medical Center, Medical Center Boulevard, , . All Rights Reserved.